| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$106 |
Quarterly Activities & Cashflow Report
|
30 Jan 2025 8:23AM |
$0.180 |
$0.395 |
risen by
119.44%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- ISLA-101 shows safety and anti-dengue activity in the Phase 2a prophylactic trial.
- Phase 2b therapeutic arm commenced after Phase 2a data submission to the US FDA.
- Mr. Phillip Lynch appointed as Executive Chairman.
- A$3.5 million secured via a placement to fund clinical programs.
- Cash position of A$3.99 million as of 31 December 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NGX Limited (NGX) ORDINARY FULLY PAID |
Materials |
$11 |
December 2024 Quarterly Report
|
30 Jan 2025 8:23AM |
$0.150 |
$0.125 |
fallen by
16.67%
|
|
NGX - Price-sensitive ASX Announcement
Full Release
Key Points
- NGX is developing a portfolio of African projects focused on clean energy minerals.
- Permitting for the Tubusis uranium exploration project in Namibia progressed significantly.
- Ongoing bulk-scale optimization testing for Malingunde's downstream processing.
- NGX is enhancing AAM production from high-quality natural graphite.
- Improvements in Malingunde's upstream operations lead to higher-purity graphite concentrate.
- Peter Fox appointed as Executive Director effective 2 December 2024.
- NGX holds approximately $4.8 million in cash and has no debt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
MDR 4C 2Q FY25 Quarterly Update
|
30 Jan 2025 8:22AM |
$0.200 |
$0.022 |
fallen by
89%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- 2Q FY25 operating revenue down 38.6% to $30.8 million.
- US revenue decreased by 43.7% primarily due to deferrals in vaccine-related health programs.
- ANZ revenue increased by 1.9% to $5.4 million.
- Gross profit margin improved by 8.4 percentage points to 63.6%.
- Business restructure initiated expected to save at least $5 million annually in FY26.
- Cash on hand as of 31 December 2024 is $12.4 million.
- A formal review process has begun to evaluate strategic options for maximizing shareholder value.
- Positive first half EBITDA guidance confirmed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
30 Jan 2025 8:22AM |
$1.850 |
$1.950 |
risen by
5.41%
|
|
| Alcidion Group Limited (ALC) ORDINARY FULLY PAID |
Health Care |
$161 |
Q2 FY25 Quarterly Activities Report and Appendix 4C
|
30 Jan 2025 8:22AM |
$0.067 |
$0.120 |
risen by
79.10%
|
|
ALC - Price-sensitive ASX Announcement
Full Release
Key Points
- Q2 new sales of $13.1M TCV with $4.5M revenue expected to be recognised in FY25
- Q2 cash receipts of $9.1M with an operating cash outflow of ($0.26M)
- FY25 contracted revenue of $30.8M at end of Q2
- Cash balance of $7.7M and no debt as of 31 December 2024
- Maintaining expectation of EBITDA and cashflow positive in FY25
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Technologies Ltd (TEK) ORDINARY FULLY PAID |
Financials |
$51 |
Update - Notification of buy-back - TEK
|
30 Jan 2025 8:22AM |
$0.135 |
$0.135 |
fallen by
0%
|
|
| Wisr Limited (WZR) ORDINARY FULLY PAID |
Financials |
$55 |
WZR Company Presentation Q2FY25
|
30 Jan 2025 8:22AM |
$0.036 |
$0.031 |
fallen by
13.89%
|
|
WZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Loan originations of $93.5 million in Q2FY25, a 77% increase year-over-year.
- Average credit score improved to 798, indicating higher credit quality.
- Net losses decreased to 1.72%, showing improved performance.
- Well-capitalized with $17.9 million of unrestricted cash available for growth.
- Continued progress on a third warehouse to support scaling efforts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Capricorn Metals Ltd (CMM) ORDINARY FULLY PAID |
Materials |
$7,123 |
Change in substantial holding
|
30 Jan 2025 8:22AM |
$7.580 |
$15.615 |
risen by
106%
|
|
| Elementos Limited (ELT) ORDINARY FULLY PAID |
Materials |
$135 |
Copper, Gold & Silver Target to be Drilled at Cleveland
|
30 Jan 2025 8:22AM |
$0.060 |
$0.390 |
risen by
550%
|
|
ELT - Price-sensitive ASX Announcement
Full Release
Key Points
- Elementos identified a significant shallow target at Cleveland Tin Project.
- Target is located 70 meters below the surface.
- Target is near previous high-grade drilling results.
- Company plans to conduct follow-up drilling for further analysis.
- The target may extend in length beyond initial estimates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wisr Limited (WZR) ORDINARY FULLY PAID |
Financials |
$55 |
Wisr delivers 77% increase in loan originations
|
30 Jan 2025 8:22AM |
$0.036 |
$0.031 |
fallen by
13.89%
|
|
WZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Wisr reported a 77% increase in loan originations to $93.5 million.
- The total loan book grew to $757 million.
- Secured vehicle loan originations increased by 230% to $39.1 million.
- Net losses decreased to 1.72%, showing improved loan book performance.
- The average credit score of the loan book increased to 798.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$436 |
Update - Notification of buy-back - RG8
|
30 Jan 2025 8:22AM |
$2.150 |
$2.980 |
risen by
38.60%
|
|
| Zimplats Holdings Limited (ZIM) 10C US ORDINARY FULLY PAID |
Materials |
$2,557 |
Quarterly Activities Report
|
30 Jan 2025 8:22AM |
$11.520 |
$23.760 |
risen by
106.25%
|
|
ZIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Five lost-time injuries were recorded in the quarter.
- Milled volumes decreased by 6% year-on-year and 8% quarter-on-quarter.
- Mined volumes decreased by 7% year-on-year and 8% quarter-on-quarter.
- 6E metal in final product decreased by 21% year-on-year and 14% quarter-on-quarter.
- 6E head grade increased by 1% year-on-year and was stable quarter-on-quarter.
- Cash costs per 6E ounce increased by 3% both year-on-year and quarter-on-quarter.
- Production from Ngwarati Mine was successfully replaced by Rukodzi and Mupani mines.
- Commissioning of the expanded smelter resulted in improved smelting capacity.
- Total operating cash costs increased by 3% year-on-year and quarter-on-quarter.
- Exploration activities remained limited due to depressed metal prices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,664 |
Update - Notification of buy-back - WEB
|
30 Jan 2025 8:22AM |
$5.030 |
$4.605 |
fallen by
8.45%
|
|
| OFX Group Limited (OFX) ORDINARY FULLY PAID |
Financials |
$111 |
Update - Notification of buy-back - OFX
|
30 Jan 2025 8:22AM |
$1.385 |
$0.480 |
fallen by
65.34%
|
|
| Infini Resources Limited (I88) ORDINARY FULLY PAID |
Materials |
$30 |
Diamond Drilling Commences At Portland Creek Uranium Project
|
30 Jan 2025 8:22AM |
$0.665 |
$0.280 |
fallen by
57.89%
|
|
I88 - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden diamond drill program commenced at Portland Creek Uranium Project.
- First priority hole PCDD001 planned to be drilled to 600 meters depth.
- Drilling targets high-grade soil anomaly with peak results of 74,997 ppm U3O8.
- Project situated in tier-1 jurisdiction of Newfoundland, Canada.
- Program expected to take 6-8 weeks to complete.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SPDR S&P/ASX 200 Fund (STW) |
Financials |
$6,382 |
Daily Fund Update
|
30 Jan 2025 8:21AM |
$75.810 |
$80.110 |
risen by
5.67%
|
|
| Equatorial Resources Limited (EQX) ORDINARY FULLY PAID |
Materials |
$22 |
December 2024 Quarterly Report
|
30 Jan 2025 8:21AM |
$0.125 |
$0.170 |
risen by
36%
|
|
EQX - Price-sensitive ASX Announcement
Full Release
Key Points
- Equatorial Resources Limited is engaged in international arbitration against the Republic of Congo.
- The final hearing for the arbitration is scheduled for March 2025.
- High-grade iron mineralisation has been confirmed at the Nimba Alliance Iron Ore Project.
- An initial Exploration Target at the Nimba Alliance Project ranges between 260 to 660 million tonnes of iron mineralisation.
- The company holds approximately $12.6 million in cash as of December 31, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SPDR S&P/ASX 200 Listed Property Fund (SLF) |
Financials |
$533 |
Daily Fund Update
|
30 Jan 2025 8:21AM |
$13.500 |
$13.450 |
fallen by
0.37%
|
|
| Mitchell Services Limited (MSV) ORDINARY FULLY PAID |
Materials |
$86 |
Update - Notification of buy-back - MSV
|
30 Jan 2025 8:21AM |
$0.335 |
$0.405 |
risen by
20.90%
|
|
| SPDR S&P/ASX 50 Fund (SFY) |
Financials |
$737 |
Daily Fund Update
|
30 Jan 2025 8:21AM |
$74.400 |
$76.380 |
risen by
2.66%
|
|
| Audeara Limited (AUA) ORDINARY FULLY PAID |
Consumer Discretionary |
$13 |
Q2 FY25 Quarterly Activities Report & Appendix 4C
|
30 Jan 2025 8:21AM |
$0.037 |
$0.074 |
risen by
100%
|
|
AUA - Price-sensitive ASX Announcement
Full Release
Key Points
- Launched Clinico-branded Audeara earbuds in Taiwan.
- Achieved 70% increase in cash receipts compared to the previous period.
- Year-to-date revenue grew 211% with $2.45m including Clinico.
- Introduced Audeara Buds, targeting True Wireless audio market.
- Recognized as finalist in 2024 Australian Export awards.
- Successfully engaged at CES 2025 showcasing new technologies.
- Extended contract with world's largest audiology retailer for two more years.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MinRex Resources Limited (MRR) ORDINARY FULLY PAID |
Materials |
$26 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2025 8:21AM |
$0.008 |
$0.024 |
risen by
200%
|
|
MRR - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration activities for the quarter ended 31 December 2024 reported.
- Successful field reconnaissance and rock chip sampling completed at Sunny Corner Project.
- Best results returned from sampling include 2.85 g/t Au and 298 g/t Ag.
- Planning for further exploration activities including soil sampling and geological mapping finalized.
- Company maintains a strong cash position of $9.46 million.
- Exploration and evaluation expenditures totaled $146,220 for the quarter.
- No substantive mining production or development activities reported.
- A Section 31 Deed entered with Native Title Party for consent to prospect.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clever Culture Systems Limited (CC5) ORDINARY FULLY PAID |
Health Care |
$61 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2025 8:21AM |
$0.017 |
$0.028 |
risen by
64.71%
|
|
CC5 - Price-sensitive ASX Announcement
Full Release
Key Points
- Cashflow break-even milestone achieved for Operating Activities in the December 2024 Quarter
- Growth in sales lays foundation for a continuation of break-even or better Operating cash flows for the remainder of the Financial Year 2025
- Second order from AstraZeneca for an additional four APAS® Independence instruments
- Bristol Myers Squibb purchased first APAS® Independence instrument
- Recurring revenue growing across 20+ APAS® Independence global install base
- New APAS® Contact Plate capability to deliver a complete solution for the Pharma market
- Company name changed to Clever Culture Systems Ltd
- Total cash balance of $1.7 million and $2.3 million of receivables at 31 December 2024
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| G8 Education Limited (GEM) ORDINARY FULLY PAID |
Consumer Discretionary |
$521 |
Update - Notification of buy-back - GEM
|
30 Jan 2025 8:21AM |
$1.380 |
$0.675 |
fallen by
51.09%
|
|
| Argent Minerals Limited (ARD) ORDINARY FULLY PAID |
Materials |
$88 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2025 8:21AM |
$0.018 |
$0.052 |
risen by
188.89%
|
|
ARD - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of 7 RC drillholes at Kempfield NW Prospect confirming mineralization.
- New drill results showed high-grade silver and base metals at Kempfield.
- Rock chip sampling at Trunkey Creek identified gold up to 24 g/t.
- Company's cash reserves were reported at $1.804 million.
- Continued focus on exploration and development across multiple projects in NSW.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
